Ledger.Open graph →
SEC Form D · filed April 6, 2018

CONSTELLATION PHARMACEUTICALS INC

Offering
$100.0M
Sold
$99.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Robert A. Tepper · Cambridge, MADirectorAnthony A. Evnin · Cambridge, MADirectorJigar Raythatha · Cambridge, MAExec · DirectorPeter A. Svennilson · Cambridge, MADirectorMark A. Goldsmith · Cambridge, MADirectorJames E. Audia · Cambridge, MADirectorEmma E. Reeve · Cambridge, MAExecJared Lowe · Houston, TXDirectorKevin Chen · Brooklyn, NYExec · DirectorMark S. Fields · Vancouver, British Columbia, CanadaDirectorJonathan C. Trousdale · Dania Beach, FLDirectorSeth Rodsky · Brooklyn, NYExecWayne S. Kirk · Vancouver, British Columbia, CanadaDirectorJayendra E. Das · BOSTON, MADirectorJoseph Kinsella · BOSTON, MADirectorAriel E. Tseitlin · BOSTON, MADirectorRobert C. Mcguire · PITTSBURGH, PADirectorMichael T. Puckett · New Orleans, LADirectorBrad M. Hutensky · Hartford, CTDirectorSteven Mintz · Vancouver, British Columbia, CanadaExec · DirectorJesse Kaplan · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗